In this study, our results indicated that GTS-21, an α7nAChR agonist, inhibits hyperoxia-induced accumulation of HMGB1 in the airways of mice in a model of VAP, by attenuating the release of nuclear HMGB1. Here, HMGB1 is linked to ventilator-associated pneumonia.